Citadel Advisors
OSIR

Citadel Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Citadel Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,500
Closed -$52K – 8576
2016
Q4 		$52K Buy
+10,500
New +$53.8K ﹤0.01% 6865
2016
Q3 		– Sell
-11,900
Closed -$61K – 8342
2016
Q2 		$61K Sell
11,900
-8,900
-43% -$47.9K ﹤0.01% 6365
2016
Q1 		$119K Buy
20,800
+8,800
+73% +$61.5K ﹤0.01% 5955
2015
Q4 		$125K Buy
12,000
+4,200
+54% +$57K ﹤0.01% 6444
2015
Q3 		$144K Sell
7,800
-8,000
-51% -$154K ﹤0.01% 6555
2015
Q2 		$307K Buy
15,800
+3,700
+31% +$65.5K ﹤0.01% 5711
2015
Q1 		$213K Buy
12,100
+7,900
+188% +$133K ﹤0.01% 6103
2014
Q4 		$67K Buy
4,200
+3,000
+250% +$40.2K ﹤0.01% 6985
2014
Q3 		$15K Sell
1,200
-2,000
-63% -$28.5K ﹤0.01% 7640
2014
Q2 		$50K Sell
3,200
-1,900
-37% -$27.9K ﹤0.01% 6748
2014
Q1 		$67K Sell
5,100
-2,700
-35% -$42.2K ﹤0.01% 6534
2013
Q4 		$125K Sell
7,800
-1,700
-18% -$27.1K ﹤0.01% 5433
2013
Q3 		$158K Buy
9,500
+3,900
+70% +$57.7K ﹤0.01% 4987
2013
Q2 		$56K Buy
+5,600
New +$58.8K ﹤0.01% 5609

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Citadel Advisors's OSIR Position: Q1 2017 in Review

Citadel Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 15,242 shares — an estimated $75K sold.

Citadel Advisors first reported a position in OSIR in Q2 2013 and held it in 11 quarters. The position peaked at $2.24M in Q1 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Citadel Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 15,242 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $75K.
  • Citadel Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Citadel Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $2.24M in Q1 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.